AI assistant
Sending…
BioAtla, Inc. — Director's Dealing 2023
Dec 19, 2023
34681_dirs_2023-12-19_0da575fd-be07-4ba9-b14f-002f2f1528e5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BioAtla, Inc. (BCAB)
CIK: 0001826892
Period of Report: 2023-12-19
Reporting Person: Vasquez Christian (See Remarks)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-12-19 | Common Stock | P | 7495 | $2.0363 | Acquired | 115659 | Direct |
Footnotes
F1: The range of prices for the shares of Common Stock is from $2.02 to $2.04. The Reporting Person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price.
F2: Includes shares purchased under the Issuer's ESPP Plan.
More from BioAtla, Inc.
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
Mar 23
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Mar 2
Regulatory Filings
2026
Feb 11
Regulatory Filings
2026
Feb 9
Regulatory Filings
2026
Feb 6